Tag

Pepfar

All articles tagged with #pepfar

Wrong Place, Wrong Labels: State Dept Map Mislabels Africa at AIDS Conference
world29 days ago

Wrong Place, Wrong Labels: State Dept Map Mislabels Africa at AIDS Conference

At the AIDS 2026 conference in Rio, a State Department slide mislabelled Africa, putting Nigeria (where the U.S. has troops) in the Sahara, Mozambique in the Horn of Africa, and Ivory Coast on the far side of the continent; Reuters found the image bore an AI watermark suggesting OpenAI tools were used. The department apologized, saying a team member hastily updated the slide, and noted that despite the slip, PEPFAR work continues and discussions remained substantive.

US map blunder at AIDS conference stirs Africa policy scrutiny
world29 days ago

US map blunder at AIDS conference stirs Africa policy scrutiny

A State Department slide at the AIDS 2026 conference in Rio de Janeiro showed an AI-generated map of Africa with multiple mislabels (Nigeria depicted as landlocked in the Sahara, Mozambique misplaced, Côte d’Ivoire off its proper location), prompting online screenshots and scrutiny. The department apologized, saying a team member hastily updated the deck and that the map carried an OpenAI watermark. Pepfar’s core work has largely resumed after a prior pause, but the US is scaling back some prevention and surveillance funding and plans to fully phase out the program in South Africa.

Pepfar funding cuts trigger global HIV service disruptions, study finds
world1 month ago

Pepfar funding cuts trigger global HIV service disruptions, study finds

New research presented at AIDS 2026 shows that US cuts to PEPFAR disrupted HIV programs in 46 countries, forcing the closure of about 1,700 sites and laying off around 16,000 staff, with prevention and mother-to-child transmission services hit hardest as organizations also reshaped operations to comply with DEI and other US policy restrictions, risking reversing years of progress against HIV.

US HIV Aid at a Tipping Point as Funding Cliff Looms
world1 month ago

US HIV Aid at a Tipping Point as Funding Cliff Looms

Millions relying on US-funded HIV/AIDS programs face an uncertain future as a funding cliff nears: 120 CDC-backed PEPFAR awards expire with no clear replacement, potentially disrupting testing, treatment, PrEP and lab services for more than 8.7 million patients worldwide, especially in Mozambique, Tanzania and South Africa; the State Department’s restructuring could shift control away from CDC, prompting concerns among health experts that services and surveillance could suffer even as officials promise continuity and increased funding in other areas.

US to phase down Pepfar funding for South Africa's HIV programs amid policy tensions
world2 months ago

US to phase down Pepfar funding for South Africa's HIV programs amid policy tensions

The United States will begin phasing out the Pepfar funding that supported South Africa’s HIV programs, citing SA’s insufficient progress on U.S. policy requests and a push for self-reliance. Pepfar previously accounted for about a fifth of SA’s HIV spending, though antiretrovirals are government-funded. The move comes amid fraught US-South Africa relations under the Trump administration, including accusations of Afrikaner persecution.

Zambian brothers fend for themselves after AIDS deaths and aid cuts
world2 months ago

Zambian brothers fend for themselves after AIDS deaths and aid cuts

Three brothers in Zambia's Copperbelt, ages 17, 15 and 12, are fending for themselves after their HIV-positive parents died this year as aid cuts shuttered the clinics that kept them on meds; they sell belongings, live in a leaky home, and Joseph works as a part-time security guard to pay rent and cover schooling while trying to keep his brothers on treatment, aided only by a pastor and distant relatives as the broader HIV-care network wanes.

Ebola surge tests global response as FDA leadership reshapes U.S. health policy
health3 months ago

Ebola surge tests global response as FDA leadership reshapes U.S. health policy

The Ebola outbreak in the Democratic Republic of Congo is worsening and likely undercounted, with spread to Uganda and a Rwanda travel ban for those linked to the DRC, though experts say travel bans don’t stop spread. Momentum for a dedicated U.S. men’s health office remains uncertain ahead of midterms. Acting FDA Commissioner Kyle Diamantas is consolidating leadership amid a reshuffle. A Lancet study puts global mental disorders at 1.17 billion in 2023, underscoring rising need. Eight former CDC directors warn against hasty changes to PEPFAR, arguing the program’s evolution must be careful to preserve its gains.

Trump's HIV funding cuts leave treatment steady but prevention and data reporting falter
future-perfect4 months ago

Trump's HIV funding cuts leave treatment steady but prevention and data reporting falter

Official data show PEPFAR kept about 20 million people on HIV treatment in mid-2025, but prevention work deteriorated sharply: roughly 4 million fewer people were tested in Q4 2025, new treatment starts fell, PrEP enrollments dropped about 41%, and prevention programs for key populations collapsed to near zero, all amid workforce cuts and less transparent reporting—raising concerns of a hidden, long-term HIV surge despite seemingly steady treatment numbers.

US shifts HIV relief to country-led deals, risking data gaps and stalled progress
world4 months ago

US shifts HIV relief to country-led deals, risking data gaps and stalled progress

The United States is moving away from the centralized PEPFAR framework to a patchwork of bilateral country partnerships, prompting concerns about reduced oversight and weaker data collection just as HIV testing, PrEP uptake, and pediatric treatment decline; experts warn the pace could hinder ongoing progress toward ending the epidemic, despite PEPFAR's historic impact.

South Africa's HIV fight braces as US aid wanes
health6 months ago

South Africa's HIV fight braces as US aid wanes

US funding for South Africa’s HIV response has been cut, risking about $400m a year and threatening testing, treatment and prevention services. SA offered emergency funds and a bridge plan, but experts warn gaps could raise new infections if mobile clinics and data systems shut down. Rollouts like Lenacapavir and CAB-LA depend on sustained funding, and the government is seeking additional support from the Global Fund and other donors as Washington signals a permanent shift to 'America First Global Health Strategy'.

PEPFAR and Gilead Collaborate to Expand HIV Prevention with Breakthrough Drug
health11 months ago

PEPFAR and Gilead Collaborate to Expand HIV Prevention with Breakthrough Drug

The U.S. Department of State announced a PEPFAR initiative to bring Gilead Sciences' breakthrough HIV drug lenacapavir to high-burden countries, aiming to reach up to 2 million people by 2028. The twice-yearly injectable medication, which has shown over 99% effectiveness in clinical trials, will be distributed with the support of the U.S. government and the Global Fund, at no profit from Gilead, to help prevent mother-to-child transmission and reduce HIV infections globally.

The Future of PEPFAR Amid Funding Uncertainties
health1 year ago

The Future of PEPFAR Amid Funding Uncertainties

PEPFAR, the U.S. initiative to combat HIV/AIDS, narrowly avoided significant funding cuts in 2023, which caused disruptions in clinics and treatment programs worldwide. While the program's future remains uncertain due to expired authorization and shifting priorities, some experts see a renewed bipartisan commitment and a move towards increased international ownership, though challenges persist in maintaining progress against HIV/AIDS globally.